CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Nonobstructive Coronary Plaque on Cardiac CT: Alarming or Not?

Published: Tue, 15 Aug 2017 14:43:47 EDT
This finding "requires action," a CT imager says, while a noninterventionalist counters there are no data showing improved outcomes by identifying nonobstructive plaque in healthy people, and there are downsides.
Medscape Medical News

Key Factors Distinguish Transient Post-Stroke Symptoms

Published: Tue, 15 Aug 2017 14:38:27 EDT
Investigators have identified key risk factors, triggers, and clinical features of transient post-stroke recrudescence in findings that may help clinicians distinguish this phenomenon from new stroke symptoms.
Medscape Medical News

New Anti-VEGF Drug Promising for Wet Macular Degeneration

Published: Tue, 15 Aug 2017 14:16:11 EDT
OPT-302, a new vascular endothelial growth factor (VEGF) inhibitor, appears to be safe and shows signs it could slow the progression of neovascular age-related macular degeneration.
Medscape Medical News
Displaying results 16-18 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

NantHealth cuts staff, offloads assets as Q2 losses hit $70M

Published: Fri, 11 Aug 2017 08:58:36 +0000
NantHealth is cutting its headcount by 300 through layoffs and the sale of assets to Allscripts. The reduction, which amounts to about one-third of NantHealth’s headcount, will lower costs at the Patrick Soon-Shiong-helmed company after a quarter in which it lost $70 million.

Chutes & Ladders—David Epstein expands title at Rubius to executive chairman

Published: Thu, 10 Aug 2017 20:53:59 +0000
David Epstein was named executive chairman of Rubius Therapeutics, ex-PTC executive Mark Rothera jumped ship to helm Orchard Therapeutics and Maverick tapped former Pacira COO James Scibetta as CEO. Plus more hirings, firings and retirings throughout the industry.

RNA-targeting CRISPR could yield treatments for Huntington's, ALS

Published: Thu, 10 Aug 2017 15:58:20 +0000
Researchers from the University of California, San Diego, have used a new version of CRISPR to fix problems in RNA rather than to edit DNA, a promising step for a group of diseases, including Huntington’s and amyotrophic lateral sclerosis, that have no cure.
Displaying results 16-18 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top